Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin’s lymphoma: report on three cases and literature review

Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin’s lymphoma: report on three cases and literature review

The poor prognosis of refractory or relapsed (R/R) classical Hodgkin’s lymphoma (cHL) after autologous stem cell transplantation has improved greatly due to the introduction of brentuximab vedotin and PD-1 inhibitors. However, the duration of response achieved with these novel agents is too short. T...

Full description

Bibliographic Details
Main Authors: Samuel Romero, Aitana Balaguer-Roselló, Juan Montoro, Paola Beneit, Amelia Martínez, Cristina Ruiz, Rafael Andreu, Manuel Guerreiro, Mario Arnao, Alberto Montava, Ana I. Vicente, Isidro Jarque, Jaime Sanz
Format: Article
Language:English
Published: SAGE Publishing 2021-08-01
Series:Therapeutic Advances in Hematology
Online Access:https://doi.org/10.1177/20406207211038181

Internet

https://doi.org/10.1177/20406207211038181

Similar Items